Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 7, 2015; 21(1): 254-261
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.254
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.254
Table 4 Following therapies for initial cyclosporine responders
| Maintenance therapy | Total(n = 15) | Outcome | |
| Colectomy (n = 6) | No colectomy (n = 9) | ||
| Without azathioprine | |||
| PSL | 1 | 1 | |
| 5-ASA+PSL | 4 | 3 | 1 |
| PSL+neoral | 1 | 1 | |
| 5-AZA+PSL+neoral+LCAP | 1 | 1 | |
| With azathioprine | |||
| 5-ASA+PSL+AZA | 1 | 1 | |
| 5-ASA+PSL+neoral+AZA | 5 | 5 | |
| 5-ASA+PSL+neoral+TAC+AZA | 1 | 1 | |
| 5-ASA+PSL+neoral+LCAP+AZA | 1 | 1 | |
- Citation: Miyake N, Ando T, Ishiguro K, Maeda O, Watanabe O, Hirayama Y, Maeda K, Morise K, Matsushita M, Furukawa K, Funasaka K, Nakamura M, Miyahara R, Ohmiya N, Goto H. Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis. World J Gastroenterol 2015; 21(1): 254-261
- URL: https://www.wjgnet.com/1007-9327/full/v21/i1/254.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i1.254